Cite
Design and synthesis of potent 1,2,4-trisubstituted imidazolinone derivatives with dual p38αMAPK and ERK1/2 inhibitory activity.
MLA
Awadallah, Fadi M., et al. “Design and Synthesis of Potent 1,2,4-Trisubstituted Imidazolinone Derivatives with Dual P38αMAPK and ERK1/2 Inhibitory Activity.” European Journal of Medicinal Chemistry, vol. 94, Apr. 2015, pp. 397–404. EBSCOhost, https://doi.org/10.1016/j.ejmech.2015.03.008.
APA
Awadallah, F. M., Abou-Seri, S. M., Abdulla, M. M., & Georgey, H. H. (2015). Design and synthesis of potent 1,2,4-trisubstituted imidazolinone derivatives with dual p38αMAPK and ERK1/2 inhibitory activity. European Journal of Medicinal Chemistry, 94, 397–404. https://doi.org/10.1016/j.ejmech.2015.03.008
Chicago
Awadallah, Fadi M, Sahar M Abou-Seri, Mohamed M Abdulla, and Hanan H Georgey. 2015. “Design and Synthesis of Potent 1,2,4-Trisubstituted Imidazolinone Derivatives with Dual P38αMAPK and ERK1/2 Inhibitory Activity.” European Journal of Medicinal Chemistry 94 (April): 397–404. doi:10.1016/j.ejmech.2015.03.008.